Nebulizers versus pressurized metered-dose inhalers in preschool children with wheezing

Christine Smith1, Ran D Goldman

  • 1BC Children’s Hospital, Department of Pediatrics, Room K4-226, Ambulatory Care Bldg, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.

Insights

For preschool children with wheezing, using a pressurized metered-dose inhaler with a spacer is an effective delivery method for inhaled bronchodilators. Ensure the child is awake and cooperative for optimal medication administration.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Wheezing is a common symptom in preschool children.
  • Inhaled bronchodilators are frequently prescribed for pediatric wheezing.
  • Optimal drug delivery methods are crucial for effective treatment in young children.

Purpose of the Study:

  • To determine the recommended delivery method for inhaled bronchodilators in preschool children.
  • To compare the efficacy of nebulizers versus metered-dose inhalers with spacers.

Main Methods:

  • Review of current clinical guidelines and evidence.
  • Analysis of drug delivery efficiency based on device type and patient age.
  • Consideration of factors influencing medication adherence and cooperation.

Main Results:

  • Pressurized metered-dose inhalers (pMDIs) with spacers are effective for delivering inhaled medications to young children.
  • Children under 5 years of age may require a face mask in conjunction with a spacer.
  • Administering aerosolized medications while the child is awake improves delivery.

Conclusions:

  • pMDIs with spacers offer an effective alternative to nebulizers for pediatric patients.
  • Optimizing device selection (e.g., mouthpiece vs. face mask) and patient cooperation enhances bronchodilator delivery.
  • Proper technique and patient engagement are key to successful inhaled therapy in young children.
Abstract

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...